Despite the overarching understanding that PD-1/PD-L1 expression serves as a critical mechanism for immune evasion by tumour cells, some subsets of endometrial cancer patients seem to exhibit limited or even absent PD-1/PD-L1 expression. Here, CD274 is linked to neoplasm.